NEURO-ONCOLOGY, a leading journal published by OXFORD UNIVERSIT PRESS INC, is at the forefront of research in the intersection of neurology and oncology, with contributions spanning from 1999 to 2024. With a recognized impact reflected in its strong ranking, holding Q1 status in Cancer Research, Neurology (Clinical), and Oncology categories, NEURO-ONCOLOGY provides a vital platform for the dissemination of groundbreaking studies and advancements in brain tumor research and treatment. The journal ranks impressively within the 99th percentile in clinical neurology and 96th percentile in oncology, highlighting its significance and influence within the field. Accessible through institutional subscriptions, it serves as a valuable resource for researchers, healthcare professionals, and students seeking to stay informed of the latest developments, therapeutic strategies, and scientific discussions in neuro-oncology.

Indian Journal of Neurosurgery, published by GEORG THIEME VERLAG KG, serves as a pivotal resource in the field of neurosurgery and clinical neurology. With an ISSN of 2277-954X and E-ISSN 2277-9167, this Open Access journal has made significant strides since its transition to an accessible format in 2012, ensuring that groundbreaking research is available to the global scientific community. The journal, situated in Stuttgart, Germany, aims to publish high-quality and innovative research, reviews, and discussions that address contemporary challenges in neurosurgery. Despite its recent ranking of 465/551 in Medicine (Surgery) and 361/400 in Medicine (Neurology - clinical), with percentiles of 15% and 9% respectively, the Indian Journal of Neurosurgery fosters a platform for emerging ideas that can propel advancements in neurosurgical practices. Researchers, professionals, and students are encouraged to contribute to and benefit from this dynamic publication, which continues to influence the evolution of neurosurgical knowledge and practices.

JOURNAL OF CLINICAL NEUROSCIENCE is an esteemed publication dedicated to advancing the field of neurology and related medical disciplines. Published by ELSEVIER SCI LTD, this journal serves as a vital resource for researchers, clinicians, and educators, providing a platform for the dissemination of high-quality research findings since its inception in 1994. With a noteworthy impact factor and ranked within the Q2 and Q3 categories across various medical specialties, including neurology and surgery, the journal positions itself at the forefront of clinical neuroscience. Although it operates under a traditional subscription model, the journal’s commitment to publishing rigorous scientific work ensures that it remains an integral reference for anyone involved in the diagnosis, treatment, and understanding of neurological disorders. Readers can access a diverse array of articles that not only highlight current research trends but also foster the exchange of innovative ideas in clinical practice.

Brain and Spine is a premier academic journal published by ELSEVIER, dedicated to advancing the fields of neuroscience and neurology. With its unique focus on the complex interactions between brain function and spinal health, this journal serves as an essential resource for researchers, clinicians, and students alike. Though currently lacking an official impact factor, its ranking within Scopus highlights its relevance, placing it in the 25th percentile for neuroscience (miscellaneous) and the 23rd percentile within neurology, indicating that while it is a developing journal, it holds potential for significant contributions to the field. Operating under open-access principles, it aims to disseminate valuable findings widely, ensuring that novel insights into neurological health are accessible to a global audience. Brain and Spine seeks to foster interdisciplinary collaboration and innovation, making it an invaluable platform for those striving to enhance our understanding of the brain and spinal cord's intricate functions and interdependencies.

Neurosurgical Focus, an esteemed journal published by the American Association of Neurological Surgeons, stands at the forefront of neurosurgical research and clinical practice. With its ISSN 1092-0684, this peer-reviewed publication has made a significant impact in the fields of Medicine, Neurology, and Surgery, consistently ranking in the top quartile (Q1) across these categories based on the 2023 metrics. The journal, which spans a rich temporal landscape from 2000 to 2024, offers a platform for disseminating vital research findings, insightful reviews, and innovative surgical techniques. While it is not open access, its high Scopus rankings—40th out of 551 in Medicine & Surgery and 97th out of 400 in Neurology—highlight its broader influence and the quality of research it curates. As an essential resource for researchers, clinicians, and students, Neurosurgical Focus is dedicated to advancing the field of neurosurgery and fostering intellectual discourse within the community.

CLINICAL NEUROLOGY AND NEUROSURGERY, published by Elsevier, is a pivotal journal in the fields of neurology and neurosurgery, recognized for its rigorous peer-review process and commitment to advancing clinical practices. Established in 1974, the journal has become a respected source of innovative research, evidenced by its excellent Scopus rankings—placing it within the top half of journals in both Medicine (Surgery) and the clinical aspect of Neurology. Notably, it has achieved a Q2 ranking in both Medicine (miscellaneous) and Surgery, and Q3 in Neurology (clinical) as of 2023. The journal publishes a wide array of articles focused on the latest findings, clinical practices, and technological advancements that address neurological disorders and surgical interventions. While it does not currently operate under an open-access model, it remains highly accessible to academic institutions and professionals worldwide from its editorial base in the Netherlands. By enabling knowledge-sharing and fostering collaboration among researchers, practitioners, and students, CLINICAL NEUROLOGY AND NEUROSURGERY plays a crucial role in shaping the future of clinical neurology and surgical techniques.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, published by Oxford University Press Inc, stands as a pivotal resource for advancing research and knowledge in the domains of neuropathology and experimental neurology. Established in 1942, this esteemed journal has expanded its influence, as evidenced by its Q1 rankings in both Neurology (clinical) and Pathology and Forensic Medicine, along with its strong placement in Cellular and Molecular Neuroscience. With an emphasis on innovative research and clinical practices, it caters to a diverse audience, including researchers and clinicians dedicated to understanding neurological disorders through a multidisciplinary lens. While not open access, this journal provides access to cutting-edge studies that are pivotal in shaping the future of medical science and pathology. Researchers benefit from its rigorous peer-review process, ensuring the publication of high-caliber work that meets the evolving demands of the field.

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

Frontiers in Oncology is a premier open access journal dedicated to advancing the field of oncology through innovative research and knowledge dissemination. Published by FRONTIERS MEDIA SA since 2011, this journal is based in Switzerland and holds an impressive Q2 ranking in both Cancer Research and Oncology as of 2023, highlighting its significance in the academic community. With its commitment to open access, Frontiers in Oncology ensures that vital research is readily available to researchers, healthcare professionals, and students around the globe, enhancing collaboration and fostering breakthroughs in cancer research. The journal's robust Scopus rankings further illustrate its academic influence, with notable positions in the fields of Oncology and Cancer Research. By covering a wide range of topics within oncology, this journal serves as a vital resource, supporting the rapid evolution of cancer treatment, diagnostics, and patient care strategies.

ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.